Retinopathy of Prematurity: all 169 studies

Page 2 of 2. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.

• Acupuncture for Preterm Infants Requiring Eye-examCompletedNCT03650621Not applicable
• Efficacy of Mydriatic Drops in Premature InfantsCompletedNCT03448640
• Optical Coherence Tomography Angiography (OCT-A) in Children (≥ 6 <14 Years of Age)WithdrawnNCT03399825
• WINROP Algorithm Validation for Retinopathy Screening in a Cohort of Premature InfantsCompletedNCT03347799
• Refractive Error and Biometry in Retinopathy of PrematurityCompletedNCT03334513
• Effect of Vitamin E for Prevention of Retinopathy of Prematurity: A Randomized Clinical Trial.CompletedNCT03274596Not applicable
• A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature InfantsActive, not recruitingNCT03253263Phase 2
• Multi-Center Study to Determine the Role of Fatty Acids in Serum in Preventing Retinopathy of Prematurity (MDM)CompletedNCT03201588Not applicable
• Effects of Early Vitamin A Supplementation on the Risk for Retinopathy of Prematurity in Extremely Preterm InfantsCompletedNCT03154723Not applicable
• VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROPCompletedNCT03148132Phase 4
• Serum Vascular Endothelial Growth Factor in Infants With Intravitreal RanibizumabCompletedNCT03115255Not applicable
• a Prospective Cohort Study for Propranolol Treatment in Retinopathy of PrematurityStatus unknownNCT03038295Phase 2
• Oral Propranolol Improve Retinopathy of Prematurity Outcomes in Very Preterm InfantsStatus unknownNCT02977000Not applicable
• Analyzing Retinal Microanatomy in ROPCompletedNCT02887157
• Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born InfantsCompletedNCT02820662Not applicable
• Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in TurkeyCompletedNCT02814929
• Infant-parent Skin-to-skin Contact During Screening for RetinopathyCompletedNCT02780544Not applicable
• A Fatty Acids Study in Preventing Retinopathy of PrematurityCompletedNCT02760472Phase 3
• Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of PrematurityCompletedNCT02683317Not applicable
• Performance of a Photoscreener for Vision Screening in a Haitian Pediatric PopulationWithdrawnNCT02655432
• Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)CompletedNCT02504944Phase 2
• UK Surveillance of Treated Retinopathy of PrematurityCompletedNCT02484989
• Telemedicine Approaches to Evaluating Acute-Phase ROP eROP Implementation ProjectTerminatedNCT02257307
• Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus DiseaseCompletedNCT02164604Not applicable
• Cost-effectiveness of Tele-expertise for Premature Infants for RetinopathyCompletedNCT02157727
• Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of PrematurityCompletedNCT02134457Phase 2
• Oral Vitamin A Supplementation in Neonates With Birth Weight < 1500 gCompletedNCT02102711Not applicable
• Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1Status unknownNCT02090322Not applicable
• Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm NeonatesStatus unknownNCT02050971Phase 1
• Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of PrematureCompletedNCT02014454Phase 2
• The Efficacy of Paracetamol in Reducing Pain During Ophthalmological Examination for Retinopathy of Prematurity: a Prospective Randomised TrialStatus unknownNCT01872871Not applicable
• REDEXAM - Reducing Painful Eye Examinations in Preterm InfantsCompletedNCT01861470
• Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of PrematurityCompletedNCT01780155
• Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.Status unknownNCT01707745Not applicable
• Registry for Severe ROP and Treatment on Visual OutcomesCompletedNCT01559571
• VEGF In Systemic Circulation Of ROP-infantsWithdrawnNCT01470430
• Ascorbyl Peroxide Association With Bronchopulmonary DysplasiaCompletedNCT01439295
• Retinopathy of Prematurity:Summary of a DecadeCompletedNCT01363960
• A Scan Ultrasonography in the Evaluation of Retinopathy of PrematurityTerminatedNCT01335113
• Telemedicine Approaches to Evaluating Acute-phase ROPCompletedNCT01264276
• Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)WithdrawnNCT01232777Phase 2
• Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of PrematurityCompletedNCT01203436Phase 2/3
• Trial to Evaluate a Specified Type of Apgar (TEST-APGAR) Follow Up StudyStatus unknownNCT01186627
• Appropriate Oxygen Levels for Extremely Preterm Infants: a Prospective Meta-analysisCompletedNCT01124331Not applicable
• Safety and Efficacy of Propranolol in Newborns With Retinopathy of PrematurityCompletedNCT01079715Phase 2/3
• Study on Effective Mydriasis in Premature InfantsCompletedNCT01054027Not applicable
• Sucrose Analgesia for the Reduction of Pain During Retinopathy of Prematurity ScreeningCompletedNCT00921544Phase 4
• Recombinant Erythropoietin for Neuroprotection in Very Preterm InfantsStatus unknownNCT00910234Phase 1/2
• Pain in Neonates During Screening for Retinopathy of Prematurity Using Two MethodsCompletedNCT00895869
• Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With CarotenoidsCompletedNCT00872664Not applicable
• Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)No longer availableNCT00870636
• Time Outside Target Oxygen Saturation Range in Preterm Infants and Long Term Outcomes and Preterm InfantsCompletedNCT00845624
• Urine VEGF Levels in Very Low Birth Weight (VLBW) InfantsStatus unknownNCT00799721
• Pan-VEGF Blockade for the Treatment of Retinopathy of PrematurityTerminatedNCT00702819Phase 1
• Pain Response During Examination for Retinopathy of PrematurityCompletedNCT00648687Not applicable
• Inhaled Nitrous Oxide for Pain Relief During Eye Exam in the Pre-term InfantCompletedNCT00623220Phase 3
• VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and VWithdrawnNCT00563121Phase 4
• Vascular Endothelial Growth Factor in Stage V ROPTerminatedNCT00500396Phase 4
• Heredity of Retinal Vessel TortuosityCompletedNCT00427063
• Vitamin A and Very Low Birthweight Babies (VitAL)CompletedNCT00417404Phase 4
• Single-Dose Intravenous Inositol Pharmacokinetics in Preterm InfantsCompletedNCT00349726Phase 2
• Erythropoietin and Early Iron Supplement and Retinopathy of PrematurityStatus unknownNCT00339001
• Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of PrematurityCompletedNCT00279669
• Cysteine Supplementation in Critically Ill NeonatesStatus unknownNCT00254176Phase 2/3
• Premature Infants in Need of Transfusion (PINT)CompletedNCT00182390Phase 3
• Use of Sucrose to Relieve Pain During Eye Exams in InfantsTerminatedNCT00161694Not applicable
• The Early Treatment for Retinopathy of Prematurity Study (ETROP)Status unknownNCT00027222Phase 2/3
• The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)CompletedNCT00000156Phase 3
• Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of PrematurityCompletedNCT00000133Not applicable

← Retinopathy of Prematurity overview